233 related articles for article (PubMed ID: 25030421)
21. Autophagy downstream of endosomal Toll-like receptor signaling in macrophages is a key mechanism for resistance to
Franco LH; Fleuri AKA; Pellison NC; Quirino GFS; Horta CV; de Carvalho RVH; Oliveira SC; Zamboni DS
J Biol Chem; 2017 Aug; 292(32):13087-13096. PubMed ID: 28607148
[TBL] [Abstract][Full Text] [Related]
22. Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo.
Liu Y; Stewart KN; Bishop E; Marek CJ; Kluth DC; Rees AJ; Wilson HM
J Immunol; 2008 May; 180(9):6270-8. PubMed ID: 18424750
[TBL] [Abstract][Full Text] [Related]
23. Macrophage Polarization in the Skin Lesion Caused by Neotropical Species of
Sandoval Pacheco CM; Araujo Flores GV; Gonzalez K; de Castro Gomes CM; Passero LFD; Tomokane TY; Sosa-Ochoa W; Zúniga C; Calzada J; Saldaña A; Corbett CEP; Silveira FT; Laurenti MD
J Immunol Res; 2021; 2021():5596876. PubMed ID: 33937417
[TBL] [Abstract][Full Text] [Related]
24. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
25. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major.
Noben-Trauth N; Lira R; Nagase H; Paul WE; Sacks DL
J Immunol; 2003 May; 170(10):5152-8. PubMed ID: 12734362
[TBL] [Abstract][Full Text] [Related]
26. Caffeic acid combined with autoclaved Leishmania major boosted the protection of infected BALB/c mice by enhancing IgG2 production, IFN-γ/TGF-β and iNO synthase/arginase1 ratios, and the death of infected phagocytes.
Belkhelfa-Slimani R; Djerdjouri B
Inflammopharmacology; 2018 Apr; 26(2):621-634. PubMed ID: 28988279
[TBL] [Abstract][Full Text] [Related]
27. The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.
Kuang Z; Lewis RS; Curtis JM; Zhan Y; Saunders BM; Babon JJ; Kolesnik TB; Low A; Masters SL; Willson TA; Kedzierski L; Yao S; Handman E; Norton RS; Nicholson SE
J Cell Biol; 2010 Jul; 190(1):129-41. PubMed ID: 20603330
[TBL] [Abstract][Full Text] [Related]
28. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
29. Combinatorial delivery of antigen and TLR agonists via PLGA nanoparticles modulates Leishmania major-infected-macrophages activation.
Katebi A; Varshochian R; Riazi-Rad F; Ganjalikhani-Hakemi M; Ajdary S
Biomed Pharmacother; 2021 May; 137():111276. PubMed ID: 33485119
[TBL] [Abstract][Full Text] [Related]
30. NMAAP1 Expressed in BCG-Activated Macrophage Promotes M1 Macrophage Polarization.
Liu Q; Tian Y; Zhao X; Jing H; Xie Q; Li P; Li D; Yan D; Zhu X
Mol Cells; 2015 Oct; 38(10):886-94. PubMed ID: 26429502
[TBL] [Abstract][Full Text] [Related]
31. Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.
Srivastava S; Pandey SP; Jha MK; Chandel HS; Saha B
Clin Exp Immunol; 2013 Jun; 172(3):403-9. PubMed ID: 23600828
[TBL] [Abstract][Full Text] [Related]
32. An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis.
Gaur U; Roberts SC; Dalvi RP; Corraliza I; Ullman B; Wilson ME
J Immunol; 2007 Dec; 179(12):8446-53. PubMed ID: 18056391
[TBL] [Abstract][Full Text] [Related]
33. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
Arendse B; Van Snick J; Brombacher F
J Immunol; 2005 Feb; 174(4):2205-11. PubMed ID: 15699153
[TBL] [Abstract][Full Text] [Related]
34. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice.
De Trez C; Magez S; Akira S; Ryffel B; Carlier Y; Muraille E
PLoS Pathog; 2009 Jun; 5(6):e1000494. PubMed ID: 19557162
[TBL] [Abstract][Full Text] [Related]
35. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
36. Mannose receptor high, M2 dermal macrophages mediate nonhealing
Lee SH; Charmoy M; Romano A; Paun A; Chaves MM; Cope FO; Ralph DA; Sacks DL
J Exp Med; 2018 Jan; 215(1):357-375. PubMed ID: 29247046
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of CD40-induced N-Ras activation reduces leishmania major infection.
Chakraborty S; Srivastava A; Jha MK; Nair A; Pandey SP; Srivastava N; Kumari S; Singh S; Krishnasastry MV; Saha B
J Immunol; 2015 Apr; 194(8):3852-60. PubMed ID: 25786685
[TBL] [Abstract][Full Text] [Related]
38. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.
Conrad SM; Strauss-Ayali D; Field AE; Mack M; Mosser DM
Infect Immun; 2007 Feb; 75(2):653-65. PubMed ID: 17088347
[TBL] [Abstract][Full Text] [Related]
39. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase.
Blos M; Schleicher U; Soares Rocha FJ; Meissner U; Röllinghoff M; Bogdan C
Eur J Immunol; 2003 May; 33(5):1224-34. PubMed ID: 12731047
[TBL] [Abstract][Full Text] [Related]
40. A critical role for suppressor of cytokine signalling 3 in promoting M1 macrophage activation and function in vitro and in vivo.
Arnold CE; Whyte CS; Gordon P; Barker RN; Rees AJ; Wilson HM
Immunology; 2014 Jan; 141(1):96-110. PubMed ID: 24088176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
